CRISPR THERAPEUTICS AG
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2015 | — | -10,416.6% | -10,325.1% |
| FY2016 | — | -1,319.3% | -448.8% |
| FY2017 | — | -157.7% | -166.7% |
| FY2018 | — | -5,097.6% | -5,291.2% |
| FY2019 | — | 16.1% | 23.0% |
| FY2020 | — | -75,572.5% | -74,384.9% |
| FY2021 | — | 40.8% | 41.3% |
| FY2022 | — | -56,190.4% | -54,271.7% |
| FY2023 | — | -59.9% | -41.4% |
| FY2024 | — | -1,250.4% | -981.5% |